Skip to main content

Table 3 Indications and the relative prevalence (%) of drug consumption in this sample in reference to the general female prevalence (%)in Flanders [23]

From: Health-related costs in a sample of premenopausal non-diabetic overweight or obese females in Antwerp region: a cost-of-illness analysis

Indication

Study sample

Population [23]

Prevalence (%)

Prevalence (%)

Pain

53.3

3.5

Depression

16.7

3.1

Cardiovascular problems

16.7

11.9

Allergy

13.3

2.4

Stomach problems

11.7

2.7

Infections

6.7

1.6

Endocrine problems

3.3

2.7

Dietary supplements

3.3

a

Birth control

10.0

4.2

Inflammation

13.3

3.6

  1. aunknown